Brown M A, Trew P A, Smart R C
Aust N Z J Med. 1983 Dec;13(6):608-12. doi: 10.1111/j.1445-5994.1983.tb02614.x.
A study was conducted in oliguric and acutely azotemic patients, measuring: (i) the fractional excretion of sodium (FENa) using creatinine clearance as a measure of glomerular filtration rate, and (ii) sodium clearance relative to urea clearance, designated as the sodium/urea clearance ratio (Na:urea CR). It was found that FENa discriminated between "tubular" and "non-tubular" disorders in 96% of patients. Further, Na:urea CR was as discriminating as FENa. Patients with Na:urea CR above 2.5% can be reliably diagnosed as having acute tubular necrosis or acute urinary tract obstruction; those with a value less than 2.5% will have acute glomerulonephritis or pre-renal azotemia. As urea and sodium measurements are so readily available, this test can now be applied in the assessment of the oliguric or acutely azotemic patient in any hospital practice.
对少尿和急性氮质血症患者进行了一项研究,测量:(i)使用肌酐清除率作为肾小球滤过率的指标来计算钠的分数排泄(FENa),以及(ii)相对于尿素清除率的钠清除率,称为钠/尿素清除率(Na:urea CR)。结果发现,FENa在96%的患者中能够区分“肾小管性”和“非肾小管性”疾病。此外,Na:urea CR与FENa具有相同的鉴别能力。Na:urea CR高于2.5%的患者可被可靠诊断为急性肾小管坏死或急性尿路梗阻;该值低于2.5%的患者则患有急性肾小球肾炎或肾前性氮质血症。由于尿素和钠的测量很容易获得,现在这项检测可应用于任何医院对少尿或急性氮质血症患者的评估。